James J. Donohue - 24 Jun 2021 Form 3 Insider Report for Acurx Pharmaceuticals, Inc. (ACXP)

Role
Director
Signature
/s/ James Donohue
Issuer symbol
ACXP
Transactions as of
24 Jun 2021
Net transactions value
$0
Form type
3
Filing time
24 Jun 2021, 18:25:02 UTC
Next filing
06 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ACXP Common Stock 12,500 24 Jun 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ACXP Warrants for Common Stock 24 Jun 2021 Common Stock 6,250 $2.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the conversion of membership interests to common stock pursuant to the corporate conversion of Acurx Pharmaceuticals, Inc.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney